Hypertension Medications and Diuretics Flashcards
Chlorothiazide Drug Class
Thiazide Diuretic
Chlorothiazide (Diuril) Indication
Hypertension
Edema
Chlorothiazide (Diuril) MOA
Reduces blood volume
Prevents reabsorption of sodium in the distal tubule. (This allows a greater urine output since water will follow salt)
Chlorothiazide Side Effects
Hypokalemia, hyperglycemia, orthostatic hypertension,
hyperuricemia, dehydration
Chlorothiazide Nursing Considerations
Nocturia if taken at night
Check potassium levels before administration- if levels are less than 3.5, mEq/L then hold
Chlorothiazide Drug to Drug interactions
Potential for Digoxin toxicity
and
Lithium toxicity
furosemide (Lasix)
Drug Classification
Loop Diuretic
Furosemide (Lasix) Indications
Hypertension
Heart Failure
Conditions where reducing volume is a goal
furosemide (Lasix) MOA
Reduces blood volume by preventing the reabsorption of sodium and chloride in the ascending loop of Henle and thereby the reabsorption of water- this promotes rapid diuresis
furosemide (Lasix) Side Effects
Hypokalemia
Hypotension
Digoxin Toxicity
Ototoxicity
furosemide (Lasix) Nursing Considerations
Oral or IV
Assess serum potassium level prior to and after administration. Do not administer if K+ level < 3.5 mEq/L May need to provide K supplementation Causes profound diuresis!
Drug to drug effects of Furosemide (Lasix)
digoxin – hypokalemia is dangerous with digoxin
Nitrates/other antihypertensive – increased hypotensive effects
Other ototoxic drugs (aminoglycoside antibiotics)
lithium – lithium toxicity
NSAIDS can attenuate the diuretic effect of furosemide
Spironolactone (Aldactone) Drug Class
Potassium Sparing Diuretic
Spironolactone (Aldactone)
Hypertension
Edema
Heart Failure
Spironolactone (Aldactone) MOA
Aldosterone reception blocker
Promotes excretion of sodium and chloride
Promotes renal retention of K+
Prevent the reabsorption of sodium from the collecting tubule and duct
Spironolactone (Aldactone) Side Effects
Hyperkalemia
Spironolactone (Aldactone) Nursing Considerations
Assess K+ levels Prior to administration
Hold if >5.5 m Eq/L
Spironolactone (Aldactone) Drug to Drug Interactions
Potassium supplements and salt substitutes (KCl) are contraindicated
ACE inhibitors or ARBs may exacerbate the tendency for hyperkalemia
Lisinopril (Zestril) Drug Class
ACE Inhibitor
Lisinopril (Zestril) indication
Hypertension
Heart Failure
Myocardial Infarction
Lisinopril (Zestril) MOA
Blocks ACE 1 to ACE 2
Increase levels of bradykinin
Lisinopril (Zestril) Side Effects
Hypotension
Hyperkalemia
Allergic Reactions
Cough
Lisinopril (Zestril) Nursing Considerations
Assess HR and BP prior to administration
Drug to Drug Interactions
Diuretics
Intensify hypotension
Antihypertensive agents
Intensify hypotension
Drugs that raise potassium
Increased risk of hyperkalemia
Lithium
Lithium toxicity
NSAIDS
Reduce efficacy of ACE inhibitors
Valsartan (Diovan) Drug Class
Angiotensin Receptor Blocker
Valsartan (Diovan) Indications
Hypertension
Heart Failure
Myocardial Infarction
Valsartan (Diovan) MOA
Blocks access of angiotensin II to its receptors, thus causing decreased blood pressure and lowering blood volume
Valsartan (Diovan) Side Effects
Hypotension
Hyperkalemia
Avoid in Pregnancy
Valsartan (Diovan) Nursing Considerations
Assess HR and BP prior to administration
Monitor Kidney function
Valsartan (Diovan) Drug to Drug Interactions
Antihypertensive drugs intensify hypotension
Metoprolol (Lopressor) Drug Classification
Beta Adrenergic Blocker
Metoprolol (Lopressor)
Hypertension
Angina pectoris
Heart failure
Cardiac Dysrhythmias
Metoprolol (Lopressor) MOA
Reduces heart rate
Reduces force of contraction
Reduces conduction through the AV node
Reduces secretion of renin by the kidney
Metoprolol (Lopressor) Side Effects
Cardiac - heart failure, AV block, and sinus arrest., bradycardia
Hypotension can occur secondary to reduced cardiac output
In patients with asthma, blocking beta2 receptors in the lung can cause bronchospasm.
Metoprolol (Lopressor) Nursing Considerations
Assess apical BP and HR prior to administration. Notify HCP if < 60 bpm
Bradycardia
Hypotension
Hold if pt. report SOB
Metoprolol (Lopressor) Side Effects
Cardiac - heart failure, AV block, and sinus arrest., bradycardia
Hypotension can occur secondary to reduced cardiac output
In patients with asthma, blocking beta2 receptors in the lung can cause bronchospasm.
Metoprolol (Lopressor) Drug to Drug Interactions
Calcium Channel Blockers
Intensifies cardiac effects of beta blockers
Insulin
Prevents compensatory glycogenolysis in response to insulin induced hypoglycemia; diabetic patients may need to reduce insulin dosing
amlodipine (Norvasc) Drug Class
Calcium Channel Blocker
amlodipine (Norvasc) Indications
Hypertension
Edema
amlodipine (Norvasc) MOA
Selective blockade of calcium channels in VSM
Promote vasodilation
amlodipine (Norvasc) Side Effects
Peripheral and facial edema
Flushing
Dizziness
Headache
Amlodipine (Norvasc) Nursing Considerations
Assess HR and BP prior to administration
Increased risk of digoxin toxicity
do not crush/chew
Amlodipine (Norvasc) Drug to Drug Interactions
Beta-adrenergic Blockers
Decrease the cardiac effects
atorvastatin (Lipitor) Drug Classification
Statin
atorvastatin (Lipitor) Indications
Hypercholesterolemia
Prevention of cardiovascular events
MI, stroke, angina
Diabetes
ADA: Diabetic pts > 40 y.o. with more than one risk factor for cardiovascular disease, regardless of lipid levels
All pts with known CV disease regardless of lipid levels
atorvastatin (Lipitor) MOA
Reduce cholesterol synthesis in liver
Increase LDL receptors (most important)
Decrease LDLs
Increase HDLs Decrease triglycerides Anti-inflammatory
atorvastatin (Lipitor)
Myopathy
Rhabdomyolysis
Hepatotoxicity
atorvastatin (Lipitor) Nursing Considerations
Timing:
Results within 2 weeks; maximal 4-6 weeks
If drug is stopped, serum cholesterol returns to pretreatment levels (lifelong treatment)
cholestyramine (Questran) Drug Class
BILE ACID SEQUESTRANTS
cholestyramine (Questran) Indications
Increased LDL levels
Cholestyramine MOA
Absorb bile acids in the intestine
New bile acids must be synthesized
Cholestyramine Side Effects
GI symptoms constipation, bloating, indigestion, nausea
Cholestyramine Nursing Considerations
Take oral medications 1 hour before or 4 hours after the bile acid sequestrant
ezetimibe (Zetia) Drug Class
Cholesterol Absorption Inhibitors
ezetimibe (Zetia) Indications
Lowers total cholesterol, LDLs, TG and raises HDLs
Used as adjunct to diet modification
ezetimibe (Zetia) MOA
Acts in GI tract to inhibits cholesterol absorption
Blocks absorption of dietary cholesterol and cholesterol secreted in bile
ezetimibe (Zetia) Side Effects
Myopathy
Hepatitis
Pancreatitis
Thrombocytopenia
ezetimibe (Zetia) Nursing Considerations
do not give to patients in hepatic failure
fenofibrate (TriCor) Drug Class
Fibrates
Fenofibrate (TriCor) Indications
Hypercholesterolemia
Low HDL
High TG
Fenofibrate (TriCor) MOA
Lower LDL
Lowers TG
Increases HDL
Fenofibrate (TriCor) Side Effects
gallstones
myopathy
hepatotoxicity
Fenofibrate Nursing Considerations
Because of overlapping adverse effects, the combo of a statin and a fibric acid derivative should be used with great caution